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T H E  D I V E R S I T Y  D I V I D E N D ? 
CONTEXT
Over the past decade, the need for greater diversity and 
inclusion across research systems has received greater 
emphasis from policymakers, funders, universities and 
stakeholders. It is also a priority for the Wellcome Trust, which 
funded this project3. 
Strategies in support of diversity and inclusion need to be 
underpinned by the best available evidence. As a contribution 
to this, a multidisciplinary research team from the University 
of Sheffield undertook a mapping review of the evidence for a 
positive relationship between a diverse and inclusive biomedical 
and health research community, and the qualities and impacts 
of its research. A second stage of the project explored and 
evaluated the relationship between the metrics used to measure 
diversity, inclusion, quality and impact in health research. 
T H E  D I V E R S I T Y  D I V I D E N D ? 
CHALLENGES OF MEASURING DIVERSITY 
AND INCLUSION
It is important to start by considering the extent to which 
diversity and inclusion are being treated as means to 
particular ends (such as efficiency or productivity), or as ends 
in themselves (such as equality and rights). There are also 
challenges in conceptualising and measuring diversity and 
inclusion, including:
• Diversity is measured in different ways according to the 
level of analysis; for example this may be done at a group, 
organisational or societal level;
• Some axes of difference and disadvantage have had more 
analysis than others; other areas are less well covered in 
the research base;
• Measures of inclusivity (or discrimination) need to 
go beyond measuring the make-up of groups and 
representativeness to look at how they function, and 
degrees of inclusivity or discrimination;
• Measures that are meaningful in the UK may be irrelevant in 
many other settings
CHALLENGES OF MEASURING DIVERSITY 
AND INCLUSION 
The biomedical and health research system is also complex, 
with many actors. Any analysis of diversity and inclusion across 
this system requires looking at more than simply those who 
primarily identify themselves as ‘researchers’. There are 
increasing expectations that the public, patients and carers 
should be active players in shaping research agendas. Individuals 
also play multiple roles: as researchers; research users; funding 
board members; journal reviewers and editors; and patients. 
Different interests and views about the overarching purposes 
of the health research system also influence perceptions of 
diversity and inclusion. These include: health research as a 
source of wealth (new drugs and technologies etc.); health 
research as a means of increasing overall health; health research 
as a means of reducing inequalities in health outcomes between 
groups, populations and/or countries. Ideas about whether, why 
and how issues of diversity and inclusion should be addressed 
will depend on perceptions of the appropriate mix and priority 
between these different purposes.
MEASURING RESEARCH QUALITIES AND 
IMPACTS
Similarly, ideas about what constitutes high-quality or high-
impact research depend on different perceptions about the 
purposes of research. In recent years, researchers have come 
under growing pressure to measure and demonstrate the 
value they contribute to society. This pressure takes a variety 
of forms: greater demands for audit and evaluation of public 
investment in research; requests from policymakers for more 
strategic intelligence on research impacts; institutional needs 
to manage and develop research strategies; competition within 
and between institutions for prestige, students, staff and 
resources; and more availability of real-time data on research 
uptake, and the capacity of tools for analysing them.
Policies and initiatives to promote diversity and inclusion in the 
research system can be undermined if the indicators used to 
define and measure success (in terms of “quality”, “excellence”, 
“impact”) reinforce existing inequalities and hierarchies. Diversity 
in the choice and use of indicators is itself a priority.
METHODOLOGY
A systematic mapping review is a method used to analyse a 
broad field, in order to identify gaps in knowledge or future 
research needs. Its objective differs from a formal systematic 
review as it does not involve data extraction, critical appraisal 
and synthesis of results, in an attempt to provide an answer 
to a specific question, but instead aims to provide a broader 
understanding of a wider topic or issue.
Coding for the systematic mapping review was undertaken 
using the PROGRESS-Plus framework, developed by the 
Cochrane Equity Group for analysis of equality and diversity 
issues in health. It aimed to identify evidence over a twenty-year 
period, from 1995 to 2015. 
From an initial set of 1466 studies, the review generated 246 
papers for detailed analysis. A full account of the search 
methods used can be found in the project’s review and mapping 
protocol4. The review evidence was supplemented by three 
qualitative institutional case studies; a stakeholder workshop; 
and a targeted look at evidence for the relationship between 
research metrics, diversity and inclusion.
The database collated for this review is now available as a 
searchable resource on Wellcome Trust’s website, to enable 
further interrogation of subsets of studies5. 
1. For more details about this project, contact Prof. James Wilsdon 
 j.wilsdon@sheffield.ac.uk 
2. http://www.nature.com/news/diversity-challenge-1.15930 
3. https://wellcome.ac.uk/what-we-do/our-work/diversity-and-inclusion 
4. https://figshare.com/articles/Review_of_diversity_and_inclusion_liter-
ature_and_an_evaluation_of_methodologies_and_metrics_relating_to_
health_research_systematic_mapping_protocol/3483140
5. https://wellcome.ac.uk/what-we-do/our-work/diversity-and-inclusion
“There is growing evidence that 
embracing diversity – in all its senses 
– is the key to doing good science. But 
there is still work to be done to ensure 
that inclusivity is the default, not the 
exception.” Diversity challenge, Nature 
editorial, 16 September 20142
T H E  D I V E R S I T Y  D I V I D E N D ? 
RESULTS AND KEY THEMES FROM THE 
MAPPING REVIEW
Of the 246 included studies, over half were published after 
2005, suggesting an upward trend in the volume of research 
in this area. The majority of empirical studies were US-based. 
Gender/sex was by far the most commonly investigated of 
the PROGRESS-Plus dimensions, followed by race/ethnicity, 
socioeconomic status, and place (broadly defined to 
include place of residence, place of work and other relevant 
geographical characteristics). 
Relatively small numbers of studies investigated sexual 
orientation, age, disability, pregnancy and maternity, and gender 
reassignment in relation to the health and biomedical research 
system. In terms of research system elements, similar numbers 
of papers were coded for research participants and research 
workforce, and a large number of papers explored research 
outputs (largely referring to academic publications). Many 
papers were coded against multiple research system elements.
While the majority of papers took a national focus, a few 
highlighted global patterns of exclusion from health research, 
and the limited amount of funded health research that relates 
to health conditions more commonly experienced in developing 
countries. 
Table 1 - Distribution of studies by PROGRESS-Plus dimensions 
and research system elements
PROGRESS+ dimensions1 Number of included studies
Gender/sex 131
Race/ethnicity/culture/
language
91
Socioeconomic status 29
Place 25
Age 11
Sexual orientation 9
Pregnancy and maternity 5
Disability 5
Social capital 3
Gender reassignment 2
Marriage and civil partnership 1
Religion 0
Occupation2 0
Education2 0
Other or non-specific 
inequalities3
9
Research system elements1 Number of included studies
Research workforce 85
Research outputs 78
Participants 65
Research methodology and 
methods
47
Agendas and topics 35
Funders and funding 30
Research ethics and 
standards
19
Patient and public 
involvement
14
Research evidence use 2
Whole system/generic 6
Other 1
Notes: 1:multiple coding possible; 2: these factors likely subsumed under 
socioeconomic status; 3: included parental status; substance users; stigmatised 
illness.
Close examination of the retrieved papers indicated two main 
clusters: (i) those that focused on the diversity of the research 
workforce, career progression and productivity in terms of 
publications and grant capture, and (ii) those that focused 
on diversity and inclusion in relation to research participants, 
topics and agendas. 
In both sets of papers, the bulk of the material was descriptive 
and non-interventional, providing only limited evidence on the 
relationships between elements of the research system and the 
focus question driving the review. A smaller number of papers 
were concerned with other aspects of the research system and/
or took a more holistic approach. These two main clusters are 
explored in more depth below.
T H E  D I V E R S I T Y  D I V I D E N D ? 
THE RESEARCH WORKFORCE
85 of the 246 publications coded for the review were identified 
as addressing research workforce issues.
RATIONALES FOR DIVERSITY AND INCLUSION 
Nine papers included a ‘business case’ type rationale for 
their interest in increasing diversity and inclusion in the 
workforce, making reference to competitiveness, creativity, 
and productivity. These papers tended to draw selectively on 
evidence from other sectors to make this case. Six of these 
papers included dual rationales, emphasising the ‘business case’ 
for greater diversity as well as an equity and fairness argument.
Arguments advanced in relation to increasing the diversity of the 
research workforce were also linked to broader health equity 
concerns. Several papers explicitly argued that researchers 
from under-represented groups are better equipped and 
more likely to pursue research on the health needs of these 
groups. But these mechanisms were assumed, rather than 
demonstrated empirically. Four further papers had a single 
focus on equity and fairness. Two referred to initiatives aimed at 
enhancing the research workforce ability to undertake research 
in ways that better meet the needs of under-served groups and 
serve to ‘democratise knowledge’, and two focused on equity of 
access to opportunities and fair treatment within academia.
PATTERNS AND TRENDS OVER TIME
A number of studies examined patterns of diversity and 
inclusion within the research workforce, through the 
representation of different groups among: the academic 
hierarchy; authors of published papers; grant applicants and 
awardees; editorial boards of academic journals; and recipients 
of other types of research support. 
The majority of these studies focused on gender/sex and 
were concerned to describe women’s disadvantaged position 
in comparison with men’s. Far fewer papers focused on 
documenting the representation of racial/ethnic minorities 
within the research workforce. No papers were retrieved that 
described the make-up of the research workforce by any of the 
other PROGRESS-plus dimensions.
A large number of studies were concerned with the so-called 
‘leaky pipeline’, a term used to describe the poor representation 
of women at senior levels within academic medicine when 
compared to their numbers in training and entry-level positions. 
These studies covered a wide range of medical specialties and 
contexts but all were based in the US except for two studies that 
were conducted in Spain.
A number of US studies also looked at gender differences in 
salaries among medical/health researchers. Several studies 
examined patterns of grant applications and awards by gender. 
Though studies tended to report greater receipt of research 
funding by men, findings were often complex and difficult to 
interpret. Three studies examined the make-up of the editorial 
boards of academic journals and all found women to be under-
represented.
OBSTACLES AND ENABLERS OF DIVERSITY AND 
INCLUSION 
Research into obstacles and enablers of diversity and inclusion 
in the research workforce focused on: family and caring 
responsibilities; aspirations; individual bias and institutional 
discrimination; and more holistic analyses.
Methods used to investigate obstacles and enablers included: 
multivariate modelling and other statistical techniques to try to 
understand more about the factors that contribute to women’s 
reduced representation at higher ranks within academic 
medicine/health research; and qualitative methods to examine 
structures and processes that may operate to (dis)advantage 
particular groups, again with a predominant focus on gender. 
INTERVENTIONS AND INITIATIVES 
The review identified a number of studies or evaluations of 
interventions and initiatives aimed improving diversity and 
inclusion within the research workforce. Most of these reported 
that interventions yielded desirable outcomes in terms of 
supporting individuals from minority and underrepresented 
groups to join and remain members of the biomedical or 
health research community. However, study designs of the 
reviewed interventions are not very strong in terms of their 
appropriateness for establishing causality. And the review did 
not identify any studies that compare the outputs, impact and 
quality of research conducted by highly inclusive and diverse 
groups to those of more exclusive and homogenous cohorts of 
researchers.
The workforce-focused interventions in this review can be 
broadly categorised into two groups; education-focused and 
career-focused. The former tend to be directed to students 
and provide them with opportunities to take part in research-
related activities as part of structured skills development 
programmes that often involve mentoring. The latter relate to 
initiatives such as mentoring, coaching and career development 
awards that are aimed at increasing retention and progression 
of individuals in research careers, and these are discussed in 
terms of their capacity to improve outcomes from individuals 
from underrepresented groups.
Three papers reported on initiatives aimed at shifting wider 
cultures and structures within research organisations and 
the wider system. One study focused on under-represented 
minority racial/ethnic groups, while the other two studies 
focused on gender equality. Several papers dealt with more 
than one intervention/initiative, which could be interpreted as 
signifying the recognition of the need for a long-term, holistic 
and systemic approach. 
The interventions varied in terms of scale and scope. The 
majority of reported interventions were conducted in the US 
or Canada region. The only intervention conducted in the UK 
dealt with the effectiveness and impact of the Athena SWAN 
Charter initiative, that awards excellence status to universities 
and departments based on their policies and practices aiming 
at reducing gender bias and creating inclusive workplaces in the 
STEM fields.
T H E  D I V E R S I T Y  D I V I D E N D ? T H E  D I V E R S I T Y  D I V I D E N D ? 
RESEARCH PARTICIPANTS,  
TOPICS AND AGENDAS
65 of the 246 publications coded for the review were identified 
as addressing research participant issues.
RATIONALES FOR DIVERSITY AND INCLUSION 
Arguments in support of research being inclusive of diverse 
population groups relate to both scientific quality and to 
wider legal and ethical principles. Several studies note the 
shift over time away from a concern to avoid individual risk 
to female participants – leading to the exclusion of women 
from biomedical research – to a recognition of the liabilities 
associated with collective exclusion of women from research, 
and the benefits of inclusion. Parallel arguments are also 
presented in relation to socio-economically disadvantaged 
groups. 
However, debates regarding the inclusion and exclusion of 
particular groups in different research settings continue. A 
number of papers drew attention to the need to look beyond 
simple representation within research samples to consider: 
the analyses that are performed; the extent to which research 
addresses the health issues that are of most concern to 
disadvantaged and marginalised groups; and whether the 
outputs produced have the potential to positively impact on 
their health.
PATTERNS AND TRENDS OVER TIME
A number studies aimed to characterise research participants 
and the degree to which they were representative of the 
general population. Most of these were concerned with the 
representation of women and/or of minority racial/ethnic 
groups. Other axes of difference were examined in a smaller 
number of papers, including age (e.g. the exclusion of the elderly 
and children) and disability (e.g. the exclusion of people with 
intellectual disability or psychiatric disorders). Most papers 
examined inclusion in clinical research, rather than other 
research types, and the majority concluded that exclusion was 
unjustified.
There appears to have been significant improvement over 
time in the gender representativeness of biomedical research 
samples in the US. Progress has been slower in relation to 
minority racial/ethnic groups. For other groups, progress is less 
well documented but also appears to be slower (e.g. LGBT).
Limited evidence on patterns and trends over time in the make-
up of research participants was identified for countries other 
than the US. Some research also raises the possibility of over-
representation and ‘over-researching’ of some marginalised 
communities (e.g. minority racial/ethnic participants in Phase 
I healthy volunteer clinical trials in the US – the most risky trials).
There are significant differences in patterns of gender inclusion 
across health research specialties and disciplines (e.g. nursing 
research is one area that tends to exclude men rather than 
women). There was less evidence of a consistent shift over time 
on the agendas and topics pursued by health researchers, and 
their likely positive impact on health inequalities.
OBSTACLES AND ENABLERS OF DIVERSITY AND 
INCLUSION 
It is important to recognise both active and passive processes 
of exclusion from research studies. Passive exclusion can result 
from consent procedures for some clinical trials in the US, 
which actively exclude patients who do not speak English, or 
passively exclude individuals on linguistic or cultural grounds. 
Low levels of trust and negative attitudes towards medical 
research can also lead to a greater reluctance to participate 
among some groups.
Obstacles to the design and delivery of health research 
that addresses the health concerns of marginalised and 
disadvantaged groups are similarly multi-faceted. Researcher 
skills, confidence and tools can be insufficient to engage with 
research participants across social and cultural distance. 
Institutional cultures, structures and processes do not 
necessarily encourage research on minority health issues.
INTERVENTIONS AND INITIATIVES 
The review identified a range of initiatives across the health 
research system aimed at increasing the representation of 
excluded groups as research participants, and/or increasing 
the volume and quality of research that addresses health issues 
among minority/excluded groups. Few of these have been 
evaluated using rigorous methods, and a majority of papers 
report on descriptive studies.
Studies reporting on initiatives aimed at increasing diversity 
and inclusion in research participants and/or topics fell into five 
main categories: 
• legislation to establish guidelines for inclusion of women 
and racial/ethnic minorities in clinical research (only in the 
US); policies & guidelines developed at various levels and 
relating to various points in the health research cycle; 
• targeted investments by funding agencies or research 
institutions aimed at fostering more research in particular 
areas; 
• workforce diversification and skills development to 
encourage more representative research samples and 
research on the health needs of under-represented groups; 
• research tools and techniques to support recruitment of 
traditionally under-represented groups; and 
• community engagement and participatory methods going 
beyond recruitment of participants, to actively engage 
members of minority and marginalised groups within the 
research process.
SUMMARY OF INTERVENTIONAL 
APPROACHES AND OUTCOMES
Overall, the mapping review identified a much larger volume 
of descriptive and exploratory studies than interventional or 
evaluative studies. 25 studies were identified that presented 
some kind of evaluation of an intervention or initiative aimed 
at increasing diversity and/or inclusion within an aspect of the 
health system. Most of these addressed the diversity of the 
workforce, or of research participants. 
Those which focused on workforce issues used largely 
conventional indicators of academic performance such as 
publications written, citations, grants secured and positions 
obtained. Few metrics related to longer-term outcomes or 
evaluation, and only one study included an in-built critique of 
metrics used. Studies focused on participants tended to focus 
on quantitative aspects of recruitment and retention to trials, 
although there was some consideration of qualitative aspects of 
diversity in study samples.
DIVERSITY, INCLUSION  
AND RESPONSIBLE METRICS
Across research systems, there is a growing recognition 
that initiatives to encourage greater diversity and inclusion 
in research are likely to prove inadequate if the metrics and 
indicators that are used to define, measure, recognise and 
reward success within those systems simply reinforce existing 
inequalities and hierarchies. 
The continued dominance of a narrow range of conventional 
indicators as proxies for research quality (citations, Journal 
Impact Factors etc.) limits frames of measurement and 
assessment, shapes the way that research agendas are 
prioritized, and influences career trajectories. Concern about 
the effects that a small range of dominant metrics are having 
on research cultures is reflected in recent initiatives such as 
the San Francisco Declaration on Research Assessment (DORA), 
Leiden Manifesto and The Metric Tide6. 
Of the 246 publications coded for this review, 43 were identified 
as relating to the relationship between metrics/indicators, 
and diversity/inclusion in health research. Closer examination 
of these 43 papers indicates five main clusters: studies that 
identify inequalities and/or potential biases in conventional 
research metrics; studies that focus on the relationship 
between research metrics and career trajectories; studies 
that examine differences in authorship and editorship; studies 
that propose new metrics for qualities and impacts; studies 
that focus on indicators of diversity or inclusion in relation to 
research participants, topics and agendas.
CONCLUSIONS AND RECOMMENDATIONS
STRENGTHS AND WEAKNESSES OF THIS PROJECT:
The review presents descriptions of interventions rather than 
evaluating their effectiveness or impact. Further targeted 
searches and synthesis on the value of specific interventions, as 
a counterpoint to this broad map of activity, may be a direction 
for future activity.
The literature revealed a lack of studies using rigorous 
evaluation designs. Other relevant literature may be missing 
because indexing is problematic in certain areas. The review 
was also biased towards literature written in English.
Consultation with stakeholders allowed the review team and 
Wellcome Trust to gain a rapid understanding of the area under 
inquiry, and some of the constraints of existing practices. It 
confirmed the importance of taking a whole systems approach 
to diversity and inclusion. However, this holistic view was not 
well accommodated by approaches used in the literature, which 
tended to focus on individual interventions or programmes 
targeted at specific stages of the research process.
6. www.ascb.org/dora; http://www.nature.com/news/bibliomet-
rics-the-leiden-manifesto-for-research-metrics-1.17351; http://www.hefce.
ac.uk/pubs/rereports/Year/2015/metrictide/Title,104463,en.html 
T H E  D I V E R S I T Y  D I V I D E N D ? 
For more information about this research please contact Professor James Wilsdon, Director of Impact and Engagement in the Faculty of 
Social Sciences at University of Sheffield, on J.wilsdon@sheffield.ac.uk 
Sheffield Solutions in an ambitious initiative of the Faculty of Social Sciences at the University of Sheffield, which supports events, activities 
and outputs aimed at connecting social science perspectives to policy makers, practitioners and other external audiences in order to tackle 
pressing global issues. For further information please email sheffieldsolutions@sheffield.ac.uk
KEY FINDINGS AND OBSERVATIONS
The review highlighted ten broad conclusions about the state of 
the evidence in this area, and gaps that persist:
1. There is strong dominance of US-based research in the 
literature, which raises questions about the transferability 
of findings, given the cultural specificity of some aspects of 
diversity and inclusion.
2. There is a far more extensive literature relating to 
gender and race/ethnicity (although the latter relates 
predominantly to the US), and comparatively little on other 
axes of difference. The literature highlights persistent 
patterns of disadvantage, but also variability by field and 
subfield – particularly with regard to gender.
3. The majority of the studies we examined focused on clinical 
or biomedical research. Other areas of health-related 
research did not feature so heavily. Given that the relevance 
of the PROGRESS-Plus variables differ depending on the 
type of health research, and on the sub-cultures and 
degree of diversity within health research disciplines, the 
transferability of evidence across disciplines is debatable.
4. The predominant level of analysis is that of individuals 
(in terms of metrics, interventions etc.). Multiple (dis)
advantages and inter-locking aspects of people’s experience 
can reinforce one another. The degree of isolation 
and exclusion felt by women and minorities can be 
underestimated. There is a relative lack of attention paid 
in the literature to measures of diversity or inclusion at the 
aggregate or organisational level.
5. There is a focus on individual parts of the health system, 
and only a few examples of more holistic, systems-based 
and/or longitudinal approaches that try to examine how 
elements interplay and (re)create disadvantage. 
6. The literature predominantly takes a national, rather than 
international or comparative focus, despite the fact that 
dimensions of diversity and inclusion look very different 
from a more international or global perspective.
7. The studies we examined reflect a limited amount of 
theoretical framing, and often rely on implicit assumptions 
about mechanisms of action and causality, rather than 
more explicit development and testing of models and 
mechanisms.
8. There are persistent areas of controversy and complexity, 
such as how to conceptualise and operationalise race/
ethnicity. These demand careful and explicit consideration.
9. Trickle-down or trickle-out effects to other parts of health 
research systems is far from automatic: this takes time, and 
requires actions to promote diversity and inclusion across 
all elements of the system. Gender-related initiatives can 
be seen as benefiting women only. Informal processes can 
reinforce the advantages of dominant groups. Mentoring 
schemes that pay attention to culture and tacit knowledge, 
rather than simply skills, seem more promising
10. There is limited available evidence that directly addresses 
the guiding research question of this project; and 
a relatively weak evidence base for processes and 
explanations of patterns of inequality, exclusion or lack of 
diversity that are visible in the health research system.
RECOMMENDATIONS FOR FURTHER WORK:
The review made four recommendations for future research that would strengthen the evidence base in this area:
• There needs to be greater investment in comprehensive studies that examine interactions across the health research system, 
and longitudinal studies that look at changes over time at individual, collective and institutional levels. 
• More work is required to improve comparability across studies, to define and standardise indicators and metrics; and to 
collect data in consistent ways.
• There needs to be greater experimentation and research investment in neglected aspects of diversity and inclusion, including: 
aggregate measures of inclusion; axes of difference and disadvantage beyond gender and race/ethnicity; enablers and 
obstacles; and diversity and inclusion across health research systems.
• To achieve this more systemic perspective, there need to be closer links between future research on diversity and inclusion 
in health research, and issues relating to research cultures, career pipelines, reward and recognition structures, responsible 
metrics and research integrity. Given the existing portfolio of its activities, there is scope for Wellcome Trust to pioneer 
creative funding, policy and advocacy that draw links between these disparate and siloed agendas, to advance a more holistic 
understanding of links between diversity, inclusion, integrity, responsibility and public engagement. 
